Recent Grants

January 1, 2017

(as of March 1, 2017)

Christina Hoven, PhD, (Child and Adolescent Psychiatry) received an R01 grant for her project “Sleep and Well-Being in High Risk Youth” from the National Heart, Lung and Blood Institute. The four-year grant totals $3,110,624.

(as of October 20, 2016)

Martin Picard, PhD, (Behavioral Medicine) received funding from the National Institute of General Medical Sciences for the project entitled, “Mitochondrial Stress Signal Transduction from Organelle to Organism.”  The 5-year grant totals $1,996,784.

Amy Margolis, PhD, (Child and Adolescent Psychiatry) received an NIH grant for her project titled, “Effects of Prenatal Exposure to Environmental Tobacco Smoke on Brain Function and Academic Skills.” This 5-year grant totals $656,969.

 Margaret Haney PhD, (Substance Abuse) received a NIH grant for the project entitled, “Non-Metabolized Pregnenolone Derivatives: New Treatment for Cannabis Use Disorder.”  This 2-year grant totals $3,297,733.

Cristiane Duarte, PhD, (Child and Adolescent Psychiatry) Catherine Monk, PhD, (Behavioral Medicine) and Jonathan Posner, MD ((Child and Adolescent Psychiatry)) received a NIH grant for their project titled, Breaking the Cycle of Intergenerational Disadvantage: Neurodevelopment Among Puerto Rican Children.” The total amount of the grant is $4,264,846 over 2 years. 

Jiook Cha, PhD, (Child and Adolescent Psychiatry) received a NIH grant for his project titled “Neural Correlates of Fear Over-Generalization in Youth with Pathological Anxiety.” This K01 award totals $737,021 over 4 years.

Alex Dranovsky, MD, PhD (Integrative Neuroscience) received an NIH grant for his project titled, “Temporal Specification of Neuronal Function and its Relevance to Mental Health.” This grant totals $1,135,048 over 2 years.

Jeffrey Lieberman, MD, (Psychiatry) received an NIH award for his project titled Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in Schizophrenia”. This 1-year award totals $1,118,298.

Alla Landa, PhD, (Clinical Therapeutics) received an NIH grant for her project titled “Behavioral Epigenetics in Children Exploring the Social and Ethical Implications of Translation.” The K23 grant totals $982,602 over 5 years.

Barbara Stanley, PhD, (Molecular Imaging and Neuropathology) received an NIH grant for her project, “Zero Suicide Implementation and Evaluation in Outpatient Mental Health Clinics.”  This R01 grant totals $3,804,563 over 5 years.

(as of September 15, 2016)

Jaya Prabhakaran, PhD (Clinical Therapeutics) received an NIH grant for her project, “Evaluation of an [F-18] Agonist PET Ligand for 5HT2AR.” This R2 award totals $458,873 over 2 years.

Martine D. Lappe, PhD (Law, Ethics and Psychiatry) received a NIH grant for her project, “Behavioral Epigenetics in Children: Exploring the Social and Ethical Implications of Translation.” The K9 award totaled $314,456 over 2 years.

Christina Hoven, DRPH (Child and Adolescent Psychiatry) received a CDC award for her project, “9/11 Trauma and Toxicity in Childhood: Longitudinal Health and Behavioral Outcomes.” This award totals $2,976,996 over 5 years.

 Christina Hoven, DRPH (Child and Adolescent Psychiatry) received a CDC grant for her project titled, “RDoC Domains Underlying Emotional Health and Trajectories of Psychopathology in Families of WTC First Responders and Evacuees: A Genome-Wide GxE Study.” This grant totals $2,971,155 over 5 years.

Patrick Brown, PhD (Geriatric Psychiatry) received a NIH grant for his project titled, “Physical and Mental Fatigability in Late Life Clinical Populations.” This R2 award totals $458,293 over 2 years.

Jermaine Jones, PhD (Substance Abuse) received a NIH grant for his project titled, “Using Pharmacogenetics to Better Evaluate Naltrexone for Treating Stimulant Abuse.” This R2 award totals $445,500 over 2 years.

Natalie Hiromi Brito, PhD (Developmental Neuroscience) received a NIH grant for her project titled, “Examining the independent and joint contributions of socioeconomic status and bilingualism on early cognitive development.” This K9 award totals $270,727 over 2 years.

Katherine Elkington, PhD (Gender, Sexuality, and Health) received a NIH grant for her project titled, “Health and Justice: A Continuum of Care for HIV and SU for Justice-involved Youth.” This R01 award totaled $4,570,995 over 5 years.

Gaurav Patel, MD (Experimental Therapeutics) received a NIH grant for his project titled, “Neural substrates of attention and social cognition impairment in schizophrenia.” This R2 award totaled $736,279 over 4 years.

Cheryl Mary Corcoran, MD (Experimental Therapeutics) received an NIH grant for the project, “Thought disorder and social cognition in clinical risk states for schizophrenia.”  This R01 award totals $2,763,817 over 5 years.

Anthony Deo, MD (Psychiatry Resident) received a 2016 AACAP Pilot Research Award for his project BDNF and Cognition in Individuals at Clinical High-Risk for Psychosis. This 1-year award is for the amount of $15,000.

Igor Malinovsky, PsyD (Clinical Psychology) received a Youth M.O.V.E. National award for his Options: Snap Out Stigma project. The 1-year Dream America award is in the amount of $2,484.43.

Jaya Prabhakaran, PhD (Clinical Therapeutics) received an NIH grant for her project, “Development of GSK-3beta PET radioligands for in vivo imaging in brain.” The R21 award totals $451,828 over 2 years.

Jonathan Javitch, MD, PhD (Molecular Therapeutics) received an NIMH award for his project,  “Modulation of Dopaminergic Neurotransmission by ADGRL3, an Adhesion GPCR Associated with ADHD Susceptibility. ”  The grant totals $445,200 over 2 years.

 Bret Rutherford, MD (Clinical Therapeutics) received a NIH grant for his project “Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression.” His R01 award totals $1,295,876 over 2 years.

(as of June 30, 2016)

Jonathan Javitch, MD, PhD (Molecular Therapeutics) received an NIDA award for his project “Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model.” The U01 grant totals $1,961,081 over five years.

Annika Sweetland, DRPH, (Gender, Sexuality, and Health) received an NIMH award for her project " Integrating evidence-based MDD treatment in primary care: TB in Brazil as a model." The K01 grant totals $727,768 over four years.

Ragy Girgis, MD, (Experimental Therapeutics) received a Doris Duke Charitable Foundation award for his project "Dopamine Transmission in the Psychosis Prodrome: a [11C]--(+)--PHNO PET Study." The grant totals $495,000 over three years.

Maria Oquendo, MD, (Molecular Imaging) received an NIMH grant for her project entitled, “Neurobiological Underpinnings of Two Suicidal Subtypes.” Her R01 grant totals $3,350,038 over 5 years.

Thomas Smith, MD, (Behavioral Health Services and Policy Research) received an NIH grant for his project entitled “Hospital Discharge Planning and Transition to Outpatient Psychiatric Care.”  His R01 award totals $1,706,756 over 4 years.

Christoph Kellendonk, PhD, (Molecular Therapeutics) received an NIMH grant for his project, “Functionality Selective D2Rs, Striatal Circuit Function and Motivation.”  His R01 award totals $2,664,040 over five years.

Ivan Balan, PhD (Gender, Sexuality and Health) received National Institute of Child Health and Human Development grant for his project entitled “Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs.”  The R01 grant totals $2,360,618 over four years.Top of Form

(as of April 4, 2016)

Roberto Lewis Fernandez, MD, (Clinical Therapeutics) received a Communilife grant for his project “Life is Precious: Fidelity and Training Development.” The grant totals $77,708 for 1 year. 

Spiro Pantazatos, MA (Molecular Imaging) received a NIH grant for the project, “Integrative neuroinformatics to relate genomics to neurocircuitry and psychopathology.”  The K01 grant totals $739,468 over 4 years.

Deborah S. Hasin, PhD, (Clinical Phenomenology) received an NIMH grant for the project “Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints.” The R01 award totals $909,038 over 5 years.

John Markowitz, MD, (Clinical Therapeutics) received a grant for the project “Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT) for Posttraumatic Stress Disorder (PTSD)." The Psychoanalytic Research of the American Psychoanalytic Association grant totals $20,000 for one year.

Joanne Mantell, PhD, (Gender, Sexuality, and Health) received a grant for the project, “A Randomized Controlled Trial to Evaluate Adding Self-Administered HIV Testing as a Choice in Clinic and Non-Clinic Setting to Increase HIV Testing Among Truck Drivers in Kenya. The International Initiative for Impact Evolution grant subcontracted from Hunter College for one year is for $33,392.

(as of February 18, 2016)

Jurgen Kayser, PhD (Cognitive Neuroscience) received an NIMH grant for the project “EEG/ERP Measures of Attention and Cognitive Control During New Auditory WM Tasks.” The R21 award totals $445.000 over two years.

Gillinder I. Bedi, D. Psych (Substance Abuse) received a NIDA grant for the 5-year project “Neurobehavioral Mechanisms of Decisions to Smoke Marijuana and Cocaine in Humans.” The current K23 award totals $186,168 over one year.

Megan Lee Fitzgerald, PhD (Molecular Imaging & Neuropathology) received a 2015 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation for the project “Using Postmortem Brain Tissue from Depressed Suicides to Derive Induced Pluripotent Stem Cells.” The grant totals $70,000 over two years.

Davangere P. Devanand, MBBS (Geriatric Psychiatry) received a NIA grant for the 5-year project “Treatment of Psychosis and Agitation in Alzheimer’s Disease.” The current R01 award totals $579,302 over one year.

Richard W. Foltin, PhD (Substance Abuse) received a NIDA grant for the 5-year project (end-date extension to 6 years) “Hypocretin Antagonists as a Novel Approach to Medication Development.” The current R01 award totals $375,640 over one year.

(as of February 5, 2016)

Stephen Rayport, MD (Molecular Therapeutics) received a NIDA grant for the project “Mapping Dopamine Neuron Co-transmission by Proximity Detection.” The R21 award totals $257,197 over two years.

Prudence Fisher, PhD (Child and Adolescent Psychiatry) received CDC funding for the project “Development of an Epidemiologic Tool for Assessing Mental Disorders in Children Based on DSM-5 Criteria” through the University of South Carolina's CDC-funded Disability Research and Dissemination Center. The first year of the project is awarded $170,000.

Robert H. Remien, PhD (Gender, Sexuality, and Health) received $4,606,379 over five years from the National Institute of Allergy and Infectious Diseases for “Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa.”

Seonjoo Lee, PhD (Biostatistics and Data Coordination) received a NIA grant for the project, “Statistical Methods for Neural Mechanisms Mediating Cognitive System in Mental Health Research.” The K01 award totals $525,600 over four years.

Theodorus G. M. Sandfort, PhD (Gender, Sexuality, and Health) received a NIDA grant for the project, “Universal for All, Frequent for Some: HIV Testing in School-based Health Centers.” The R01 five-year award totals $3,570,953

Eduardo David Leonardo, MD (Integrative Neuroscience) received a NIMH grant for the project, “Developmental Regulation of Mood States by 5-HT1A heteroreceptors.” The R01 three-year award totals $1,592,818.

Maria A. Ramos-Olazagasti, PhD (Child and Adolescent Psychiatry) received $99,991 over two years from the Robert Wood Johnson Foundation’s New Connections: Increasing Diversity of RWJF program for the purpose of examining the role of culture and context in the transmission of risk for poor health across generations among Puerto Rican families.

Jeffrey A. Lieberman, MD (Institute Administration) was awarded $4,459,305 over 20 months from NIMH for a project entitled “New Experimental Medicine Studies: FAST-FAIL Trials in Psychotic Spectrum Disorders: Biomarker Validation Study.”

John Mann, MD (MIND) received a NIMH grant for the project, “2/2 – Familial Early-Onset Suicide Attempt Biomarkers.” The R01 five-year award totals $1,988,858.

Howard F. Andrews, PhD (Biostatistics and Data Coordination) received a grant from The Centers for Disease Control and Prevention, National Center for Birth Defects and Developmental Disabilities (NCBDDD), for the project, “Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome (FXS) to Improve Services and Outcomes-Data Coordinating Center (Component B).” The U01 five-year award totals $995,205.

Joanna E. Steinglass, MD (Clinical Therapeutics) received a NIMH grant for the project, “Neural Mechanisms of Food Choice in Anorexia Nervosa.” The R01 four-year award totals $2,163,850.

Maya Sabatello, PhD (Law, Ethics, and Psychiatry) received a NIH-HG National Human Genome Research Institute grant for the project, “Impact of Psychiatric Genetic Data Litigation and its Relationship with Stigma.” The K01 five-year award totals $871,032.

Frances R. Levin, MD (Substance Abuse) received a Substance Abuse and Mental Health Services Administration (SAMHSA) grant for the project, “Training Medical and Dental Students in SBIRT.” The three-year training award totals $736,440.

Myrna M. Weissman, PhD (Epidemiology) received $1,703,348 over two years from the John Templeton Foundation for “Understanding the Role of Belief in the Resilience of Families at Risk for Depression: Religion, Brain Structure, and Function.”

Stephen Rayport, MD (Molecular Therapeutics) received a NIDA, Drug Abuse and Addition Research Programs, award for his project ”Mapping Dopamine Neuron Co-transmission by Proximity Detection.” The R21 two-year award totals $458,870.

Christina W. Hoven, DrPH (Child and Adolescent Psychiatry) received a Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, award for her project “Context and Ethnic Diversity: Children’s Responses to 9/11.” The U01 one-year award totals $490,640.

(grants received  March - September 2015)

Frances Levin, MD, (Substance Abuse) received a NIDA K24 grant for her project “Substance Abuse Treatment Development and Clinical Research Mentoring.” The five year award totals $868,430.

Jonathan Posner, MD (Child and Adolescent Psychiatry) was awarded a St. Baldrick’s Foundation grant of $100,000 for one year for his project entitled, “Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor.”

Christina Hoven, DrPH, (Child and Adolescent Psychiatry) received a NIDA award for her project, “Cognitive Control in Children of SUD Parents: A Longitudinal Multimodal MRI.” The award totals $3,434,857 over five years.

John Keilp, PhD, (MIND) received a $75,000, two-year award from the American Foundation for Suicide Prevention for the project entitled, “Neurocognitive Markers of Vulnerability to Suicidal Behavior across the Life-cycle.”

Jared Van Snellenberg, PhD, (Translational Imaging) received a NIMH K01 award for his project, “Translational Neuroscience of Functional Connectivity in Schizophrenia.” The five year award totals $919,152.

Yuval Neria, PhD, (Clinical Therapeutics) received an NIMH R01 award for $1,696,334 over fours years for his project, “Neural Signature of Fear Overgeneralization in Trauma Exposed Adults.”

Joanna E. Steinglass, MD, (Clinical Therapeutics) received a Florence Irving Scholar award of $180,000 over three years for her project, "Neural Targets in Anorexia Nervosa: What Drives Food Choice?"

Jacquelyn Leigh Meyers, PhD (Substance Abuse) was awarded a K01 from NIDA for her project, “Gene-Environment Interaction for Cannabis Use Disorders in Blacks and Whites in the U.S.” The award totals $572,521 over five years.

Moira Rynn, MD and Rachel Marsh, PhD, (Child and Adolescent Psychiatry) received at T32 award from NIMH for “Translational Research Training in Child Psychiatry.” The one-year award amounts to $352,844.

Walter O. Bockting, PhD, (Gender, Sexuality, and Health) received a Robert N. Butler Columbia Aging Center award of $30,000 over the next year for his proposal “Social Convoy and Successful Aging among Lesbian and Gay Older Adults.”

William Fifer, PhD (Developmental Neuroscience) received a Grand Challenges Explorations grant , an initiative funded by the Bill & Melinda Gates Foundation in the amount of $100,000 for a global health and development research project, titled “Developmental Trajectories of Fetal Heart Rate Variability: A Prenatal Marker of Early Brain Development.”

(Grants received from March, 2015 through  May 2015)

Sandra Comer, PhD (Substance Abuse) received an R21 from the National Institute on Drug Abuse to fund her study, "Dynamic contrast-enhanced MRI to measure blood-brain barrier permeability in substance abusers." The total award is for two years and amounts to $420,030.

Ziva Cooper, PhD (Substance Abuse) received an R01 from the National Institute on Drug Abuse to fund her study "Preclinical synthetic cannabinoid vapor inhalation:  acute and chronic effects." The grant totals $1,433,594 over two years.

Katherine Elkington, PhD (Mental Health Services and Policy Research) received a grant from the National Institute on Drug Abuse to support her project, "Family Engagement, Cross-System Linkage to SU Treatment for Juvenile Probationers." The three-year grant amounts to $743,985.

Eduardo Francisco Gallo, PhD (Neurobiology and Behavior) was awarded a K award from the National Institute of Mental Health for his study, “D2 receptors in cholinergic interneurons:  role in striatal circuitry & motivation.” He will receive $737,156 over four years.

Stephen Rayport, MD (Molecular Therapeutics) received an R01 from the National Institute on Drug Abuse to support his project "Functional connectome analysis of amphetamine action at dopamine neuron synapses." The five-year grant totals $2,943,871.

Reuben Robbins, PhD (Gender, Sexuality and Health) received a National Institute of Nursing Research grant to fund his study, "Improving HIV care with mHealth tools:  An app to detect neurocognitive impairment." The grant amounts to $471,056 for a two-year period.

Julie Spicer, PhD (Behavioral Medicine) was awarded a grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The two-year grant will fund her study, "SES and ALLOSTATIC load: Pregnancy outcomes and maternal neurobehavior." The total award is $264,064.

(Grants received from January through March, 2015)

Don DesJarlais, PhD, (Gender, Sexuality and Health) was one of five recipients of the National Institute on Alcohol Abuse’s Avant-Garde Award for HIV/AIDS research. The grant will fund his project “Combined prevention to reduce initiation into injecting drug use.” The total award over five years will be $2,500,000.

Lisa Dixon, MD, MPH (Mental Services and Policy Research)was awarded a one-time grant from the Ittleson Foundation, Inc., to support “OnTrackUSA:  Scaling up recovery-oriented services for individuals experiencing early psychosis.” The total award is $65,000.

Jennifer Elliott, PhD (Division of Substance Abuse) received a K award from the National Institute on Alcohol Abuse and Alcoholism to support her project, “Understanding and intervening with heavy drinking among patients with HIV and HCV.” The five-year grant amounts to a total of $930,960.

Denise Kandel, PhD (Epidemiology of Substance Abuse) received an R01 for her study, “Prescription drug use in the US population: gateway effects and family patterns.” The four-year award totals $1,704,164.

Mazen Kheribek, PhD (Integrative Neuroscience) received a grant from the National Institutes of Health to support her study, “2-photon microscope for in vivo functional imaging of neuronal circuits.” The one-year award amounts to $846,619.


 

(Grants received from November 2014 through January 2015)

Harold Pincus, MD, (Mental Health Services and Policy Research) received an award from the Commonwealth Fund in support of his project, “Developing Quality Measures for Physical and Behavioral Health Care Integration.” The award totals $239,786 over one-and-a-half years.

Reuben Robbins, PhD, (Gender, Sexuality and Health) received an R21 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The grant supports her project, “A mobile app for LMIC lay health workers to screen for neurocognitive impairment.” The two-year award totals $367,699.

Joanna Steinglass, MD, (Eating Disorders) received a grant from the National Eating Disorders Association (NEDA). A total grant amount of $75,000 will support her proposal, “Changing habits in AN:  A novel approach” over three years.


2014 NARSAD Young Investigator Awards: The NARSAD Young Investigator Grant provides support for the most promising young scientists conducting neurobiological research. Two-year awards up to $60,000 or $30,000 per year are provided to enable promising investigators to either extend research fellowship training or begin careers as independent research faculty. This year, more than $12 million in 200 new two-year awards were granted.

Wesley Brian Asher, PhD, (Molecular Therapeutics) hopes to help develop better antipsychotic drugs for schizophrenia and disorders. He will apply an assay his lab developed to study aripiprazole (Abilify®) and similar drugs that do not block the activity of proteins called arrestins, which other antipsychotics do block, thus avoiding side effects common to other antipsychotics. The aim is to understand the relationship between arrestin and drug efficacy.

Christine Ann Denny, MS, PhD, (Integrative Neuroscience) will seek to identify how ketamine, a rapid-acting, still experimental antidepressant, impacts the hippocampus in mice models of depression. Her lab has developed a transgenic mouse that can permanently label neurons activated by a particular experience to reveal how hippocampal function is impaired in depression and how ketamine affects hippocampal circuits to alleviate depressive-like symptoms in the mice.

Carolyn Rodriguez, MD, PhD, (Clinical Therapeutics) will test a compound called GLYX-13 with the aim of improving treatment options for OCD. Currently available medications rarely produce complete remission and take months to work; GLYX-13 modulates activity of the receptor for glutamate, the major excitatory neurotransmitter. Dr. Rodriguez hopes to determine its mechanism of action within neural circuits implicated in OCD.

Benjamin Samuels, PhD, (Integrative Neuroscience) is exploring a potential treatment for intractable depression, based on his findings with a mouse model that activity by a growth factor in the brain called TGFβ is different in responders and non-responders to antidepressant treatment. He will characterize TGFβ signaling in depression patients to determine if manipulation of its signaling is a potential treatment for treatment-resistant depression.

Tags

Departmental News, InPsych - July 2015, New Grants